Everything below concerns 甲硫氨酸氧化. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-02-28. Numbers and descriptions here follow the published literature rather than marketing material.
Published research has focused mainly on neurological and cognitive endpoints in animal models, with proposed mechanisms involving brain-derived neurotrophic factor and related signalling pathways. A substantial share of the human data originates from a limited number of research groups, and independent replication in other countries remains sparse. Regulatory status reflects that distribution: the peptide is registered as a medicine in Russia and appears in some neighbouring markets, while elsewhere it is handled as a research chemical without approved therapeutic labelling. Questions about dose-response relationships, long-term effects, and comparability across studies are still open.
Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.
Identity and purity are confirmed with reversed-phase high-performance liquid chromatography, typically monitored at 214 nanometres where the peptide bond absorbs. Mass spectrometry, either electrospray or MALDI-TOF, verifies molecular mass against the theoretical value and detects truncation or adduct formation. Amino acid analysis and peptide mapping provide additional confirmation when required. The most frequently reported impurities are deletion sequences from incomplete coupling, methionine sulfoxide from oxidation, and dimeric species formed through non-covalent aggregation. Impurity profiles depend strongly on the synthesis and purification route chosen by the producer.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
| Property | Value | Notes |
|---|---|---|
| Purity assay | RP-HPLC, UV 214 nm | Typical research grade 95 percent or higher |
| Mass confirmation | ESI-MS or MALDI-TOF | Compared with theoretical value |
| Main degradation route | Methionine oxidation | Sulfoxide formation in solution |
| Powder storage | -20 °C, desiccated | Amber vial, minimal headspace |
| Working solution | Sterile water or saline | Prepare fresh; avoid repeated thawing |
纯度评估以反相高效液相色谱为主，通过主峰面积百分比给出粗略结果，再配合电喷雾质谱核对分子量。氨基酸分析可验证组成比例，手性色谱或毛细管电泳用于检查残基构型。常见杂质包括缺失序列的短肽、氧化产物与二聚体。由于多数市售品不附带完整检验报告，独立第三方检测常被用来核实标称值。
从分子层面看，Semax 是线性七肽，没有二硫键、糖基或脂链修饰，N 端为游离氨基，C 端为游离羧基。分子含组氨酸与谷氨酸侧链，因此在水和甲醇等极性溶剂中溶解良好，在非极性溶剂中溶解有限。计算分子量约为 814 Da，与其质子化离子的质荷比吻合，可用于质谱确认。
稳定性主要由水解与氧化两条路径支配。肽键在中性或弱酸性条件下相对稳定，遇到强碱或长时间高温则明显断裂；甲硫氨酸侧链容易被氧化成亚砜，使主峰前移并拉低实际含量。金属离子、光照和反复冻融会进一步促进降解或聚集。冻干粉在低温避光条件下可存放较长时间，配制后的水溶液通常需要冷藏并尽快用完。
Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was derived from the ACTH(4-10) fragment, a short segment of adrenocorticotropic hormone that lacks the hormonal activity associated with the full-length peptide. Researchers at the Institute of Molecular Genetics in Moscow developed the compound during the 1980s. It has been registered as a pharmaceutical product in Russia and several neighbouring countries, where it is supplied as a nasal solution, and it is also sold internationally as a research chemical.
The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.
== Family sphere == Women in France perform approximately 64% of household labor. Between 1966 and 1986, men's participation in domestic tasks increased slightly but has remained largely unchanged since. Task distribution becomes more unequal in households with two or more children, with men's involvement decreasing by about 10%. A study by INED reports that 30% of men primarily manage household chores; however, this figure does not include the 15% of children involved in family court proceedings following separation, in which fathers may take on increased caregiving and domestic responsibilities. According to a 2010 INSEE study, women spend an average of 3 hours and 26 minutes per day on domestic tasks, compared to 2 hours for men. Child custody is contested in approximately 18% of divorces. In about 90% of cases, custody is awarded to the mother, with few fathers requesting custody. Custody is awarded to fathers in about 8% of cases. Post-divorce, women experience a greater decline in standard of living compared to men. Following separation, approximately one-third of women and one-half of men enter new partnerships. Shared custody arrangements are becoming more common and now account for about 10% of divorce cases.
In January 2024, Lula accepted an invitation by Egypt president Abdel Fattah el-Sisi to visit the country, which took place on 15 February. At the meeting, Brazil and Egypt signed two agreements regarding agriculture and science cooperation. Lula also met with Arab League's secretary-general Ahmed Aboul Gheit at the League's headquarters, where he called the Israeli campaign in Gaza "inhumanity and cowardice", urging "the collective punishment" of Palestinians by Israel to stop, thus calling for a ceasefire, and all the hostages taken by Hamas to be unconditionally and immediately released. Lula equally defended the international recognition of the Palestinian state, with East Jerusalem as its capital.
=== No development reported === AD-6626 – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism AM-6527 (AM6527) – cannabinoid CB1 receptor antagonist – substance-related disorders Amitifadine (DOV-21947; EB-1010) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – alcoholism, opioid-related disorders, smoking withdrawal, substance-related disorders Arbaclofen extended release – GABAB receptor agonist – opioid-related disorders BMB-101 – serotonin 5-HT2 receptor agonist – opioid-related disorders Bupropion/mecamylamine (INT-0003; QuitPak) – combination of bupropion (norepinephrine–dopamine reuptake inhibitor (NDRI), nicotinic acetylcholine receptor negative allosteric modulator) and mecamylamine (non-selective nicotinic acetylcholine receptor antagonist) – smoking withdrawal Cannabidiol (CBD; cannabidiol transderma/topical gel/patch; Zygel; ZYN-002) – cannabinoid/various actions – alcoholism, substance-related disorders CM-1212 – undefined mechanism of action – alcoholism, substance-related disorders CPP-115 – GABA transaminase (GABA-T) inhibitor – substance-related disorders CT-044 analogues - CERSCI Therapeutics – reactive oxygen species (ROS) inhibitors (CT-044 analogues) – opioid-related disorders CX-717 (CX717) – AMPA receptor positive allosteric modulator (ampakine) – substance-related disorders Cyproheptadine/prazosin (KT-110; Periactine/Alpress) – combination of cyproheptadine (various actions) and prazosin (α1-adrenergic receptor antagonist) – substance-related disorders DCR-AUD (DCR-A1203; NN-6020) – aldehyde dehydrogenase 2 (ALDH2) inhibitor, RNA interference – alcoholism Dimethyltryptamine (DMT; EBRX-101) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – smoking withdrawal GLWL-01 – ghrelin O-acyltransferase (GOAT) inhibitor – alcoholism GSK-598809 (GSK598809) – dopamine D3 receptor antagonist – smoking withdrawal, substance-related disorders GSK-1521498 – μ-opioid receptor inverse agonist – cocaine-related disorders GTS-21 (DMXB-A; DMBX-anabaseine) – nicotinic acetylcholine receptor agonist – smoking withdrawal Icalcaprant (ABBV-1354; CVL-354) – κ-opioid receptor antagonist – substance-related disorders Levodopa (CVT-301; CXG-89; Inbrija) – dopamine precursor (non-selective dopamine receptor agonist) – smoking withdrawal Mazindol controlled release (NLS-0; NLS-1; NLS-10; NLS-13; NLS-2; Nolazol; Quilience) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – opioid-related disorders Midomafetamine (MDMA; ecstasy) – serotonin–norepinephrine–dopamine releasing agent (SNDRA), serotonin 5-HT2 receptor agonist, and entactogen – substance-related disorders Mifepristone (C-1073; Corlux; Corluxin; Korlym; Mifegyne; Mifeprex; RU-38486; RU-486) – glucocorticoid, progesterone, and androgen receptor antagonist – smoking withdrawal Modafinil oral (ASB) – atypical dopamine reuptake inhibitor (DRI) – cocaine-related disorders Naloxone nasal spray (-12; LT-20; LT-21; LT-22; Naloxon B; Narcan Nasal Spray; OPNT-001) – μ-opioid receptor antagonist – cocaine-related disorders, substance-related disorders Nalmefene implant (nalmefene six-month implant) – μ-opioid receptor antagonist, κ-opioid receptor weak partial agonist – opioid-related disorders Naloxone buccal/intransal gel (Exonal) – opioid receptor antagonist – opioid-related disorders Nicotine abuse vaccine (Niccine) – nicotinic acetylcholine receptor agonist – smoking withdrawal Nicotine/cannabidiol chewing gum (nicotine/CBD; CVSI-007) – combination of nicotine (nicotinic acetylcholine receptor agonist) and cannabidiol (CBD) (cannabinoid/various actions) – smoking withdrawal Noribogaine derived therapeutic – various actions (noribogaine derivative) – opioid-related disorders OMS-405 (OMS405) – PPARγ agonist – alcoholism Ondansetron (AD-04) – serotonin 5-HT3 receptor antagonist – opioid-related disorders, smoking withdrawal Ondansetron/topiramate (AD-01; AD/TO-01) – combination of ondansetron (serotonin 5-HT3 receptor antagonist) and topiramate (various actions) – alcoholism Ondelopran (LY-2196044; Odelepan; Odelepran; OpRA) – opioid receptor antagonist – alcoholism OPNT-005 (OPNT005; adjuvanted heroin analogue vaccine; diamorphine analogue vaccine; heroin vaccine) – immunostimulant (vaccine against heroin) – heroin-related disorders PF-5402536 (NIC7-001; PF-5402536) – immunostimulant (smoking vaccine) – smoking withdrawal Pomaglumetad methionil (DB103; LY-2140023; LY-2812223; LY-404039 prodrug) – metabotropic glutamate mGlu2 and mGlu3 receptor receptor agonist (pomaglumetad prodrug) – substance-related disorders PPL-103 – μ-opioid receptor agonist, δ-opioid receptor agonist, κ-opioid receptor agonist – substance-related disorders Pregnenolone methyl ether (3β-methoxypregnenolone; MAP-4343) – microtubule-associated protein (MAP) stimulant and tubulin polymerization promoter – substance-related disorders Psilocybin (MYCO-001; MYCO-003) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – substance-related disorders PT-150 (PT150; ORG-34517; SCH-900636) – androgen and glucocorticoid receptor antagonist – alcoholism Research programme: alcoholism therapeutics - ADial Pharmaceuticals – various actions – alcoholism Research programme: allosteric modulators - Addex Therapeutics – various actions – substance-related disorders Research programme: GPCR modulators - Nxera Pharma – various actions – cocaine-related disorders, substance-related disorders Research programme: nociceptin receptor agonists - Astraea Therapeutics – nociceptin receptor agonist, opioid receptor agonist – alcoholism, substance-related disorders Research programme: smoking cessation therapies - Ophidion – smoking withdrawal – nicotinic acetylcholine receptor agonists Research programme: tryptamine based therapeutics - PsyBio Therapeutics – serotonin 5-HT2A receptor agonists – substance-related disorders RTI-598929 – μ-opioid receptor antagonist and κ-opioid receptor antagonist – heroin-related disorders Saracatinib (AZD-0530) – Src-family kinase inhibitor – alcoholism SBP-9330 – metabotropic glutamate mGlu2 receptor modulator – smoking withdrawal SEL-068 (tSVP; immunomodulatory nanoparticle vaccine for smoking cessation) – immunomodulator (smoking vaccine) – smoking withdrawal Serdexmethylphenidate (KP-484; KP-1077; KP-1077H; KP-1077IH; KP-1077N; KP-879) – norepinephrine–dopamine reuptake inhibitor (NDRI) (dexmethylphenidate prodrug) – substance-related disorders TRV-734 (TRV734) – μ-opioid receptor biased agonist – opioid-related disorders VDM-001 – opioid receptor antagonist – alcoholism, opioid-related disorders Zolunicant (18-methoxycoronaridine; 18-MC; MM-110) – α3β4 nicotinic acetylcholine receptor antagonist – substance-related disorders
Socialist Studies 1 (1989) to 107 (2018). Socialist Studies. OCLC 723683944. 1904-2004 A Century of Political Struggle (2004) War and Capitalism (1996, 2000, 2005) OCLC 877116865 Materialist Conception of History. Socialist Studies. 1995. OCLC 863340060. The Communist Manifesto in the 21st Century. Socialist Studies. 1998. OCLC 40499662. New Labour, A Party of Capitalism. Socialist Studies. 2005 [2000]. OCLC 51075172. Socialist Policies and Principles: Setting the Record Straight. Socialist Studies. 2002. OCLC 71777907. Capitalism causes War and Terrorism. Socialist Studies. 2005 [2002]. OCLC 914627936. Socialism versus Religion, War and Capitalism (2007) Marxism in the 21st Century. Socialist Studies. 2010. OCLC 614642665.
=== Death of Asa Gilbert Eddy === Eddy's husband, Asa Gilbert Eddy, died of heart disease on June 4, 1882, shortly after the move to Boston. She invited the Boston Globe to her home on the day of his death to allege that he had been killed by malicious animal magnetism, courtesy of "certain parties here in Boston, who had sworn to injure them." The Globe wrote:
Sources: en.wikipedia.org
=== Nana Mary === Nana Mary is played by Shelley Winters. Nana Mary is Beverly's mother and Roseanne and Jackie's grandmother, and first appears at a family barbecue in season three. She has another daughter named Sonya. She makes several appearances from season three onward, mostly during family occasions. She is a brash but caring, outspoken, lovable retiree who gambles with her grandchildren. Unlike Bev, she is popular with the family. She also disagrees with Bev in certain situations, such as siding with Jackie when Bev urges her to marry Fred, and revealing that she had two abortions, upsetting Bev. She outsmarts Bev and torments her, much to the amusement of Roseanne and Jackie, who usually endure the same treatment from Bev. Her character is often a comic relief for the family, as well as offering a balance between Roseanne and Jackie's relationship with their mother, and Bev's relationship with Nana Mary. She was promiscuous in her youth and claims that as a globe-trotting free spirit she knew Pablo Picasso, Louis Armstrong, Ernest Hemingway, Fidel Castro, and Meyer Lansky, among others. Mary had Bev with another man before marrying her deceased husband, Marvin. She tells Bev she was very young when she gave birth, admits to not knowing who the father is, and avoided the subject until Bev demanded to finally know. Mary is a fan of a local radio call-in show that revolves around sex: "If I don't call, they worry," she claims.
== Genetics == Mutation in the gene CAPN3, which encodes the protein calpain-3 (CAPN3), is the cause of calpainopathy. As of 2019, more than 480 CAPN3 mutations have been reported, some of which can be associated with severe or benign disease course. Usually, the disease follows an autosomal recessive inheritance pattern, requiring both CAPN3 alleles to be mutated for disease to occur. However, there can be CAPN3 mutations that follow an autosomal dominant inheritance pattern.
239Pu is one of the three fissile materials used for the production of nuclear weapons and in some nuclear reactors as a source of energy. The other fissile materials are uranium-235 and uranium-233. 239Pu is virtually nonexistent in nature. It is made by bombarding uranium-238 with neutrons. Uranium-238 is present in quantity in most reactor fuel; hence 239Pu is continuously made in these reactors. Since 239Pu can itself be split by neutrons to release energy, 239Pu provides a portion of the energy generation in a nuclear reactor.
== History == The study of extracellular metabolites has been prevalent in scientific literature. However, global exometabolite profiling was only realized with recent advances allowing for improved chromatographic separation and detection of hundreds to thousands of compounds by the mid-2000s. The first work to demonstrate the biological relevance of comparative profiling of exometabolite pools was not until 2003, when the term "metabolite footprinting" was coined by Jess Allen and coworkers. This work attracted a great deal of interest in the community, particularly for characterization of microbial metabolism. The idea of the "exometabolome" encompassing the components of the exometabolite pool was not introduced until 2005. Recent advances in mass spectrometry imaging have allowed for spatial localization of released metabolites. As the field of microbiology becomes increasingly more centered on microbial community structure, exometabolomics has provided for rapid understanding of metabolic interactions between two or more species. Recently, exometabolomics has been used to design co-culture systems. Because the analysis of extracellular metabolites allows for the predictions and determinations of metabolite exchange, exometabolomics analyses can be used for understanding community ecological networks.
== Authors, K–Z == Mary Kaldor (born 16 March 1946); British academic of Hungarian Jewish ancestry; Professor of Global Governance at the London School of Economics and Director of the Civil Society and Human Security Research Unit; teaches at Institut Barcelona d'Estudis Internacionals (IBEI); key figure in development of cosmopolitan democracy; writes on globalisation, international relations and humanitarian intervention, global civil society and global governance and New Wars;daughter of economist, scholar and author Nicholas Kaldor Nicholas Kaldor (12 May 1908 – 30 September 1986) born Káldor Miklós, was a Cambridge economist and author of over thirty scholarly academic texts and monographs; developed the "compensation" criteria called Kaldor–Hicks efficiency for welfare comparisons (1939), derived the cobweb model, and argued for certain regularities observable in economic growth, which are called Kaldor's growth laws. Oliver Kamm (born 1963); journalist and writer who is a leader writer and columnist for The Times; The Jewish Chronicle, Prospect magazine, and The Guardian.
Sources: en.wikipedia.org
=== Other musculoskeletal === A 2014 Cochrane review of musculoskeletal injuries found very weak evidence for a decrease in pain in the short term, and no difference in function in the short, medium or long term. It has not been shown to be useful for bone healing. A 2016 review of bone graft augmentation found only one study reporting a difference in bone augmentation, while four studies found no difference. As compared to other conservative treatments for non-surgical orthopedic illnesses (e.g. steroid injection for plantar fasciitis), evidence does not support the use of PRP as a conservative treatment. A 2018 review found that evidence was lacking for Achilles tendinopathy. A 2019 meta-analysis found that, for most outcomes in Achilles tendinopathy, PRP treatment did not differ from placebo treatment. A 2019 study conducted an umbrella review that "considered studies that included populations with differing levels of physical activity, including studies on the sporting population (professional and/or recreational athletes) and studies didn't explicitly mention involving a sporting population." This inquiry reported only poor quality evidence that PRP offers any clinical benefits for treatment in acute muscle, tendon, and ligament injuries in any population.
=== United States === A CDC report for the period 2017–2019 found that 41% of outbreaks at restaurants were caused by a sick employee. Contributory factors identified included lack of written policy compliance with FDA recommendations for identifying red-flag symptoms, glove use, and hand washing; lack of paid sick leave at the majority of establishments; and social pressure to come to work even while sick. The remaining outbreaks had a variety of causes, including inadequate cooking, improper temperature, and cross-contamination. In the United States, using FoodNet data from 2000 to 2007, the CDC estimated there were 47.8 million foodborne illnesses per year (16,000 cases for 100,000 inhabitants) with 9.4 million of these caused by 31 known identified pathogens.
During protests against ICE operations in Portland, United States, some protesters flew the flag. The flag also saw use during the anti-Trump No Kings 2.0 protests in October 2025, e.g. in Los Angeles, Miami, and Spokane. In Mexico in November 2025, the flag was among various symbols used by a group identifying itself as "Generation Z Mexico", who is against drug violence that claims tens of thousands of Mexican lives each year and the security policies of Mexican president Claudia Sheinbaum. Former Mexican president Vicente Fox wore a T-shirt emblazoned with the symbol while attending the protests. Bulgarians protesting against increases in pension and social security payments in November–December 2025 used the flag. The flag was seen during the "Flamingo Revolution" in Albania. In August 2026, the Straw Hat Pirates' Jolly Roger was spray-painted on the National Monument on Dam Square in Amsterdam, alongside the phrases "Time to wake up!" and "Stop the human trafficking".
=== 2010 Pandemrix connected with narcolepsy === The Pandemrix influenza vaccine was developed by GlaxoSmithKline in 2006. It was used by Finland and Sweden in the H1N1 mass vaccination of the population against the 2009 swine flu pandemic. In August 2010, The Swedish Medical Products Agency (MPA) and The Finnish National Institute for Health and Welfare (THL) launched investigations regarding the development of narcolepsy as a possible side effect to Pandemrix flu vaccination in children, and found a 6.6-fold increased risk among children and youths, resulting in 3.6 additional cases of narcolepsy per 100,000 vaccinated subjects. In February 2011, The Finnish National Institute for Health and Welfare (THL) concluded that there is a clear connection between the Pandemrix vaccination campaign of 2009 and 2010, and the narcolepsy epidemic in Finland. A total of 152 cases of narcolepsy were found in Finland during 2009–2010, and ninety per cent of them had received the Pandemrix vaccination. Sweden however observed very few influenza cases totally in 2009 and especially 2010 as compared to most other years. In 2015, it was reported that the British Department of Health was paying for Sodium oxybate medication for 80 patients who are taking legal action over problems linked to the use of the swine flu vaccine, at a cost to the government of £12,000 per patient per year.
Gas: Volatile vapors often used for fuel. Charcoal: The solid carbon residue remaining in the kiln. Liquid distillate: The condensed vapors that form the basis for further refinement. Separation of the liquid: The liquid distillate naturally separates (or is processed) into two distinct layers:
Sources: en.wikipedia.org
Reversed-phase HPLC gives the main purity figure, most often with UV detection near 214 nanometres. Mass spectrometry then confirms the molecular mass. Together the two methods distinguish a correct sequence from a closely related impurity.
The main chemical risks are methionine oxidation and backbone hydrolysis in solution. Moisture and repeated temperature cycling accelerate both processes. Dry powder held cold and desiccated is considerably more stable than any reconstituted preparation.
It holds a medicine registration in Russia, where it has been used clinically for decades. In most other countries it is treated as a research chemical. That split explains the uneven distribution of clinical literature.
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.